CompletedNot applicableNCT00000627
Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome
Studying Histoplasmosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Wheat LJ
- Intervention
- Fluconazole(drug)
- Enrollment
- 90 target
- Eligibility
- 13 years · All sexes
- Timeline
- 1994
Study locations (23)
- Univ of Alabama at Birmingham, Birmingham, Alabama, United States
- Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
- San Francisco Veterans Administration Med Ctr, San Francisco, California, United States
- Indiana Univ Hosp, Indianapolis, Indiana, United States
- Methodist Hosp of Indiana / Life Care Clinic, Indianapolis, Indiana, United States
- Baystate Med Ctr of Springfield, Springfield, Massachusetts, United States
- Worcester Memorial Hosp / Med Ctr of Cntrl MA-Memorial, Worcester, Massachusetts, United States
- Univ of Missouri at Kansas City School of Medicine, Kansas City, Missouri, United States
- Infectious Diseases Association / Research Med Ctr, Kansas City, Missouri, United States
- St Louis Regional Hosp / St Louis Regional Med Ctr, St Louis, Missouri, United States
- Beth Israel Med Ctr, New York, New York, United States
- Cornell Univ Med Ctr, New York, New York, United States
- Saint Luke's - Roosevelt Hosp Ctr, New York, New York, United States
- Mount Sinai Med Ctr, New York, New York, United States
- Montefiore Drug Treatment Ctr / Bronx Municipal Hosp, The Bronx, New York, United States
- +8 more locations on ClinicalTrials.gov
Collaborators
Pfizer
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00000627 on ClinicalTrials.govOther trials for Histoplasmosis
Additional recruiting or active studies for the same condition.